期刊文献+

原发性高血压患者血清P-选择素和MMP-9的关系

The relationship between serum P-selectin and MMP-9 in patients with essential hypertension
下载PDF
导出
摘要 目的:通过对原发性高血压(EH)患者血清P-选择素和MMP-9水平的测定,探讨两者之间及其与血压水平的关系。方法:采用酶联免疫分析法(ELISA)分别测定40例轻、中度EH患者及30例正常对照者的血清P-选择素、MMP-9水平。结果:与对照组比较,EH患者血清P-选择素及MMP-9水平均明显增高(P<0.05)。EH患者血清P-选择素和MMP-9呈正相关(r=0.443,P=0.007);收缩压、舒张压水平与血清P-选择素和MMP-9水平之间均无相关关系。结论:轻、中度EH患者血清P-选择素和MMP-9水平显著增高,存在血小板活化及动脉粥样硬化,P-选择素和MMP-9在EH患者动脉粥样硬化发生及发展中相互影响。 Objective:To explore the serum levels of P-selectin and matrix metalloproteinase-9 (MMP-9) in essential hypertension (EH) patients and the correlation with the blood pressure. Methods:The serum P-selectin and MMP-9 in 40 mild to moderate EH patients and 30 normal controls were detected by ELISA. Results:The serum levels of P-selectin and MMP-9 were markedly increased in patients with hypertension (P0.05). The serum levels of P-selectin had a positive correlation with the serum levels of MMP-9 in EH patients (r=0.443,P=0.007). Both P-selectin and MMP-9 levels had no correlation with blood pressure. Conclusion:The P-selectin and MMP-9 of patients with mild to moderate EH increase significantly. It exists platelet activation and development of AS in the mild to moderate EH patients. Both the serum levels of P-selectin and MMP-9 have interaction in this process.
作者 黄民江 夏珂
出处 《中国医药导报》 CAS 2010年第12期22-23,共2页 China Medical Herald
关键词 原发性高血压 P-选择素 MMP-9 Essential hypertension P-selectin MMP-9
  • 相关文献

参考文献11

  • 1Massberg S, Brand K, Gruner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation [J]. J Exp Med,2002, 196(7):887-896.
  • 2Arikan E, Sen S. Endothelial damage and hemostatic markers in patients with uncomplicated mild to moderate hypertension and relationship with risk factors [J]. Clinical and Applied 147-159. ,11(2).
  • 3Offermanns S. Activation of platelet function through G protein-coupled receptors [J]. Circ Res,2006,99(12):1293-1304.
  • 4Dorsam RT, Kunapuli SP. Central role of the P2Y12 receptor in platelet activation [J]. J Clin Invest,2004,113(3):340-345.
  • 5Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events [J]. Circulation,2001,103(4):491-495.
  • 6Healy AM, Pickard MD, Pradhan AD, et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events [J]. Circulation,2006,108(19):2278- 2284.
  • 7Bemdt MC. Induction of platelet-endothelial interactions in postcapillary venules in hypercholesterolemia critical role of P-selectin [J]. Biology, 2003,23(4):525-527.
  • 8Galis ZS, Johnson C, Godin D, et al. Targeted disruption of the matrix metallopruteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling [J]. Circ Res,2002,91(9):852-860.
  • 9Armstrong C, Abilleira S, Sitzer M, et al. Polymorphisms in MMP family and TIMP genes and carotid artery intima-media thickness [J]. Stroke,2007, 38(11):2895-2899.
  • 10詹喜焱,王卉,黄琛.高血压和动脉粥样硬化患者基质金属蛋白酶-9水平的检测及临床意义[J].华中医学杂志,2005,29(3):217-218. 被引量:4

二级参考文献6

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部